Last 12 months
Inside the activity.
0 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 01, 2021 Filed Nov 3, 2021 20:46 UTC |
Murrah JudithCIO and COO
|
GrantIncentive Stock Option (right to buy) · Derivative | 19,924 | $0.00 Strike: $5.58 | $0.00 |
DisclosureSEC source: 0001104659-21-133696 · tm2131758-7_4seq1.xml · derivative · entry 1 Murrah Judith · CIK 0001624562 · CIO and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,924 Underlying: Common Stock · 19,924 shares Expires 2031-10-31 F1 · derivative.exercise_date: The options vest immediately. Read SEC document |
| November 01, 2021 Filed Nov 3, 2021 20:47 UTC |
CATELL ROBERT BDirector
|
GrantNon-Qualified Stock Option (right to buy) · Derivative | 9,948 | $0.00 Strike: $5.58 | $0.00 |
DisclosureSEC source: 0001104659-21-133699 · tm2131758-8_4seq1.xml · derivative · entry 2 CATELL ROBERT B · CIK 0001195325 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,948 Underlying: Common Stock · 9,948 shares Expires 2031-10-31 F1 · derivative.exercise_date: These options vest in full and become exercisable on the first anniversary of the date of grant, subject to continued board membership through such date. Read SEC document |
| November 01, 2021 Filed Nov 3, 2021 20:47 UTC |
CATELL ROBERT BDirector
|
GrantIncentive Stock Option (right to buy) · Derivative | 19,897 | $0.00 Strike: $5.58 | $0.00 |
DisclosureSEC source: 0001104659-21-133699 · tm2131758-8_4seq1.xml · derivative · entry 1 CATELL ROBERT B · CIK 0001195325 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,897 Underlying: Common Stock · 19,897 shares Expires 2031-10-31 F1 · derivative.exercise_date: These options vest in full and become exercisable on the first anniversary of the date of grant, subject to continued board membership through such date. Read SEC document |
| November 01, 2021 Filed Nov 3, 2021 20:45 UTC |
Ceccoli Joseph D.Director
|
GrantNon-Qualified Stock Option (right to buy) · Derivative | 10,943 | $0.00 Strike: $5.58 | $0.00 |
DisclosureSEC source: 0001104659-21-133691 · tm2131758-5_4seq1.xml · derivative · entry 2 Ceccoli Joseph D. · CIK 0001627545 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,943 Underlying: Common Stock · 10,943 shares Expires 2031-10-31 F1 · derivative.exercise_date: These options vest in full and become exercisable on the first anniversary of the date of grant, subject to continued board membership through such date. Read SEC document |
| November 01, 2021 Filed Nov 3, 2021 20:45 UTC |
Ceccoli Joseph D.Director
|
GrantIncentive Stock Option (right to buy) · Derivative | 19,897 | $0.00 Strike: $5.58 | $0.00 |
DisclosureSEC source: 0001104659-21-133691 · tm2131758-5_4seq1.xml · derivative · entry 1 Ceccoli Joseph D. · CIK 0001627545 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,897 Underlying: Common Stock · 19,897 shares Expires 2031-10-31 F1 · derivative.exercise_date: These options vest in full and become exercisable on the first anniversary of the date of grant, subject to continued board membership through such date. Read SEC document |
| November 01, 2021 Filed Nov 3, 2021 20:43 UTC |
Schmalz Elizabeth MDirector
|
GrantNon-Qualified Stock Option (right to buy) · Derivative | 9,948 | $0.00 Strike: $5.58 | $0.00 |
DisclosureSEC source: 0001104659-21-133687 · tm2131758-3_4seq1.xml · derivative · entry 2 Ferguson Elizabeth M. · CIK 0001707145 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,948 Underlying: Common Stock · 9,948 shares Expires 2031-10-31 F1 · derivative.exercise_date: These options vest in full and become exercisable on the first anniversary of the date of grant, subject to continued board membership through such date. Read SEC document |
| November 01, 2021 Filed Nov 3, 2021 20:43 UTC |
Schmalz Elizabeth MDirector
|
GrantIncentive Stock Option (right to buy) · Derivative | 19,897 | $0.00 Strike: $5.58 | $0.00 |
DisclosureSEC source: 0001104659-21-133687 · tm2131758-3_4seq1.xml · derivative · entry 1 Ferguson Elizabeth M. · CIK 0001707145 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,897 Underlying: Common Stock · 19,897 shares Expires 2031-10-31 F1 · derivative.exercise_date: These options vest in full and become exercisable on the first anniversary of the date of grant, subject to continued board membership through such date. Read SEC document |
| November 01, 2021 Filed Nov 3, 2021 20:45 UTC |
Hayward James ADirector · Chairman, CEO and President
|
GrantNon-Qualified Stock Option (right to buy) · Derivative | 199,243 | $0.00 Strike: $5.58 | $0.00 |
DisclosureSEC source: 0001104659-21-133693 · tm2131758-6_4seq1.xml · derivative · entry 2 Hayward James A · CIK 0001357784 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 199,243 Underlying: Common Stock · 199,243 shares Expires 2031-10-31 F1 · derivative.exercise_date: The options vest immediately. Read SEC document |
| November 01, 2021 Filed Nov 3, 2021 20:45 UTC |
Hayward James ADirector · Chairman, CEO and President
|
GrantIncentive Stock Option (right to buy) · Derivative | 19,924 | $0.00 Strike: $5.58 | $0.00 |
DisclosureSEC source: 0001104659-21-133693 · tm2131758-6_4seq1.xml · derivative · entry 1 Hayward James A · CIK 0001357784 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,924 Underlying: Common Stock · 19,924 shares Expires 2031-10-31 F1 · derivative.exercise_date: The options vest immediately. Read SEC document |
| November 01, 2021 Filed Nov 3, 2021 20:44 UTC |
Bitzer John IIIDirector
|
GrantNon-Qualified Stock Option (right to buy) · Derivative | 11,689 | $0.00 Strike: $5.58 | $0.00 |
DisclosureSEC source: 0001104659-21-133690 · tm2131758-4_4seq1.xml · derivative · entry 2 Bitzer John III · CIK 0001624610 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,689 Underlying: Common Stock · 11,689 shares Expires 2031-10-31 F1 · derivative.exercise_date: These options vest in full and become exercisable on the first anniversary of the date of grant, subject to continued board membership through such date. Read SEC document |
| November 01, 2021 Filed Nov 3, 2021 20:44 UTC |
Bitzer John IIIDirector
|
GrantIncentive Stock Option (right to buy) · Derivative | 19,897 | $0.00 Strike: $5.58 | $0.00 |
DisclosureSEC source: 0001104659-21-133690 · tm2131758-4_4seq1.xml · derivative · entry 1 Bitzer John III · CIK 0001624610 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,897 Underlying: Common Stock · 19,897 shares Expires 2031-10-31 F1 · derivative.exercise_date: These options vest in full and become exercisable on the first anniversary of the date of grant, subject to continued board membership through such date. Read SEC document |
| November 01, 2021 Filed Nov 3, 2021 20:42 UTC |
Shorrock ClayChief Legal Officer
|
GrantNon-Qualified Stock Option (right to buy) · Derivative | 25,205 | $0.00 Strike: $5.58 | $0.00 |
DisclosureSEC source: 0001104659-21-133686 · tm2131758-2_4seq1.xml · derivative · entry 2 Shorrock Clay · CIK 0001853671 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,205 Underlying: Common Stock · 25,205 shares Expires 2031-10-31 F1 · derivative.exercise_date: The options vest immediately. Read SEC document |
| November 01, 2021 Filed Nov 3, 2021 20:42 UTC |
Shorrock ClayChief Legal Officer
|
GrantIncentive Stock Option (right to buy) · Derivative | 19,924 | $0.00 Strike: $5.58 | $0.00 |
DisclosureSEC source: 0001104659-21-133686 · tm2131758-2_4seq1.xml · derivative · entry 1 Shorrock Clay · CIK 0001853671 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,924 Underlying: Common Stock · 19,924 shares Expires 2031-10-31 F1 · derivative.exercise_date: The options vest immediately. Read SEC document |
| November 01, 2021 Filed Nov 3, 2021 20:41 UTC |
Jantzen BethChief Financial Officer
|
GrantNon-Qualified Stock Option (right to buy) · Derivative | 25,205 | $0.00 Strike: $5.58 | $0.00 |
DisclosureSEC source: 0001104659-21-133684 · tm2131758-1_4seq1.xml · derivative · entry 2 Jantzen Beth · CIK 0001633940 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,205 Underlying: Common Stock · 25,205 shares Expires 2031-10-31 F1 · derivative.exercise_date: The options vest immediately. Read SEC document |
| November 01, 2021 Filed Nov 3, 2021 20:41 UTC |
Jantzen BethChief Financial Officer
|
GrantIncentive Stock Option (right to buy) · Derivative | 19,924 | $0.00 Strike: $5.58 | $0.00 |
DisclosureSEC source: 0001104659-21-133684 · tm2131758-1_4seq1.xml · derivative · entry 1 Jantzen Beth · CIK 0001633940 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,924 Underlying: Common Stock · 19,924 shares Expires 2031-10-31 F1 · derivative.exercise_date: The options vest immediately. Read SEC document |
| March 10, 2021 Filed Mar 11, 2021 21:02 UTC |
Anchin Scott LDirector
|
SaleCommon Stock | 29 | $8.52 | $247.08 |
DisclosureSEC source: 0001104659-21-034988 · tm219367d1_4.xml · nonDerivative · entry 5 Anchin Scott L · CIK 0001669488 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 250 Read SEC document |
| March 10, 2021 Filed Mar 11, 2021 21:02 UTC |
Anchin Scott LDirector
|
SaleCommon Stock | 201 | $8.51 | $1,710.51 |
DisclosureSEC source: 0001104659-21-034988 · tm219367d1_4.xml · nonDerivative · entry 4 Anchin Scott L · CIK 0001669488 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 279 Read SEC document |
| March 10, 2021 Filed Mar 11, 2021 21:02 UTC |
Anchin Scott LDirector
|
SaleCommon Stock | 610 | $8.45 | $5,154.50 |
DisclosureSEC source: 0001104659-21-034988 · tm219367d1_4.xml · nonDerivative · entry 3 Anchin Scott L · CIK 0001669488 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 480 Read SEC document |
| March 10, 2021 Filed Mar 11, 2021 21:02 UTC |
Anchin Scott LDirector
|
SaleCommon Stock | 210 | $8.47 | $1,778.70 |
DisclosureSEC source: 0001104659-21-034988 · tm219367d1_4.xml · nonDerivative · entry 2 Anchin Scott L · CIK 0001669488 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,090 Read SEC document |
| March 10, 2021 Filed Mar 11, 2021 21:02 UTC |
Anchin Scott LDirector
|
SaleCommon Stock | 11,999 | $8.43 | $101,151.57 |
DisclosureSEC source: 0001104659-21-034988 · tm219367d1_4.xml · nonDerivative · entry 1 Anchin Scott L · CIK 0001669488 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,300 Read SEC document |
| March 05, 2021 Filed Mar 8, 2021 21:20 UTC |
Anchin Scott LDirector
|
Exercise / conversionStock Option (right to buy) · Derivative | 9,121 | $0.00 Strike: $4.43 | $0.00 |
DisclosureSEC source: 0001104659-21-033274 · tm218955d1_4.xml · derivative · entry 4 Anchin Scott L · CIK 0001669488 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 9,121 shares Expires 2030-01-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: 9,121 of the options granted on 01/02/2020 vested and become exercisable 07/02/2020. The remaining options granted on 01/02/2020 had vesting dates that were subject to the continuation of a certain consulting agreement through 12/12/2020. The consulting agreement expired on 06/12/2020 and was not extended, and as a result, 11,665 of the options did not vest and were cancelled on 06/12/2020. Read SEC document |
| March 05, 2021 Filed Mar 8, 2021 21:20 UTC |
Anchin Scott LDirector
|
Exercise / conversionStock Option (right to buy) · Derivative | 20,834 | $0.00 Strike: $4.26 | $0.00 |
DisclosureSEC source: 0001104659-21-033274 · tm218955d1_4.xml · derivative · entry 3 Anchin Scott L · CIK 0001669488 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 20,834 shares Expires 2029-12-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: These options vested in full and become exercisable on 06/12/2020. Read SEC document |
| March 05, 2021 Filed Mar 8, 2021 21:20 UTC |
Anchin Scott LDirector
|
Exercise / conversionCommon Stock | 3,832 | $4.43 | $16,975.76 |
DisclosureSEC source: 0001104659-21-033274 · tm218955d1_4.xml · nonDerivative · entry 2 Anchin Scott L · CIK 0001669488 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,299 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 05, 2021 Filed Mar 8, 2021 21:20 UTC |
Anchin Scott LDirector
|
Exercise / conversionCommon Stock | 9,217 | $4.26 | $39,264.42 |
DisclosureSEC source: 0001104659-21-033274 · tm218955d1_4.xml · nonDerivative · entry 1 Anchin Scott L · CIK 0001669488 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,467 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 05, 2021 Filed Jan 7, 2021 21:04 UTC |
Hayward James ADirector · Chairman, CEO and President
|
GrantStock Option (right to buy) · Derivative | 80,000 | $0.00 Strike: $5.44 | $0.00 |
DisclosureSEC source: 0001104659-21-001998 · tm211881d1_4seq1.xml · derivative · entry 1 Hayward James A · CIK 0001357784 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,000 Underlying: Common Stock · 80,000 shares Expires 2031-01-04 F1 · derivative.exercise_date: The options vest immediately. Read SEC document |
| October 19, 2020 Filed Oct 21, 2020 21:22 UTC |
Murrah JudithChief Information Officer
|
GrantStock Option (right to buy) · Derivative | 13,035 | $0.00 Strike: $7.54 | $0.00 |
DisclosureSEC source: 0001104659-20-116830 · tm2033983-4_4.xml · derivative · entry 1 Murrah Judith · CIK 0001624562 · Chief Information Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,035 Underlying: Common Stock · 13,035 shares Expires 2030-10-18 F1 · derivative.exercise_date: The options vest immediately. Read SEC document |
| October 19, 2020 Filed Oct 21, 2020 21:21 UTC |
Jantzen BethChief Financial Officer
|
GrantStock Option (right to buy) · Derivative | 13,035 | $0.00 Strike: $7.54 | $0.00 |
DisclosureSEC source: 0001104659-20-116828 · tm2033983-3_4.xml · derivative · entry 1 Jantzen Beth · CIK 0001633940 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,035 Underlying: Common Stock · 13,035 shares Expires 2030-10-18 F1 · derivative.exercise_date: The options vest immediately. Read SEC document |
| October 19, 2020 Filed Oct 21, 2020 21:21 UTC |
Hayward James ADirector · Chairman, CEO and President
|
GrantStock Option (right to buy) · Derivative | 13,035 | $0.00 Strike: $7.54 | $0.00 |
DisclosureSEC source: 0001104659-20-116827 · tm2033983-2_4.xml · derivative · entry 1 Hayward James A · CIK 0001357784 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,035 Underlying: Common Stock · 13,035 shares Expires 2030-10-18 F1 · derivative.exercise_date: The options vest immediately. Read SEC document |
| October 19, 2020 Filed Oct 21, 2020 21:20 UTC |
Anchin Scott LDirector
|
GrantStock Option (right to buy) · Derivative | 18,465 | $0.00 Strike: $7.54 | $0.00 |
DisclosureSEC source: 0001104659-20-116826 · tm2033983-1_4.xml · derivative · entry 2 Anchin Scott L · CIK 0001669488 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,465 Underlying: Common Stock · 18,465 shares Expires 2030-10-18 F2 · derivative.exercise_date: These options vest on 5/22/2021. Read SEC document |
| October 19, 2020 Filed Oct 21, 2020 21:20 UTC |
Anchin Scott LDirector
|
GrantStock Option (right to buy) · Derivative | 5,573 | $0.00 Strike: $7.54 | $0.00 |
DisclosureSEC source: 0001104659-20-116826 · tm2033983-1_4.xml · derivative · entry 1 Anchin Scott L · CIK 0001669488 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,573 Underlying: Common Stock · 5,573 shares Expires 2030-10-18 F1 · derivative.exercise_date: These options vest immediately. Read SEC document |
| June 26, 2020 Filed Jun 26, 2020 22:47 UTC |
Montgomery William Wex 5% owner
|
PurchaseApplied DNA Sciences Inc. 5 year warrant · Derivative | 110,000 | $2.50 Strike: $5.25 | $275,000.00 |
DisclosureSEC source: 0001763113-20-000004 · primary_doc.xml · derivative · entry 3 Montgomery William W · CIK 0001763113 · ex 5% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Applied DNA Sciences Inc. Common Stock · 110,000 shares Expires 2024-11-15 F3 · shares: cash exercise of warrants Read SEC document |
| June 26, 2020 Filed Jun 26, 2020 22:47 UTC |
Montgomery William Wex 5% owner
|
PurchaseApplied DNA Sciences Inc. Common Stock | 110,000 | $5.25 | $577,500.00 |
DisclosureSEC source: 0001763113-20-000004 · primary_doc.xml · nonDerivative · entry 2 Montgomery William W · CIK 0001763113 · ex 5% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 245,000 F1 · price: cash exercise of warrants (see Table II) F2 · balance_after: Based on 4,928,197 shares outstanding on 6/18/20 per Beth Jantzen (CFO of APDN) - plus 110,000 shares from my warrants - my common stock ownership is 4.86% As I am no longer a 5% owner this is my final SEC filing. Read SEC document |
| June 26, 2020 Filed Jun 26, 2020 22:47 UTC |
Montgomery William Wex 5% owner
|
PurchaseApplied DNA Sciences Inc. Common Stock | 80,000 | $8.65 | $692,000.00 |
DisclosureSEC source: 0001763113-20-000004 · primary_doc.xml · nonDerivative · entry 1 Montgomery William W · CIK 0001763113 · ex 5% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 135,000 Read SEC document |
| June 18, 2020 Filed Jun 18, 2020 22:14 UTC |
Montgomery William W5% owner
|
PurchaseApplied DNA Sciences Inc. 5 year warrant · Derivative | 40,000 | $2.50 Strike: $5.25 | $100,000.00 |
DisclosureSEC source: 0001763113-20-000003 · primary_doc.xml · derivative · entry 2 Montgomery William W · CIK 0001763113 · 5% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,000 Underlying: Applied DNA Sciences Inc. Common Stock · 40,000 shares Expires 2024-11-15 F2 · shares: cash exercise of warrant F3 · balance_after: Based on 4,928,197 shares outstanding on 6/18/20 per Beth Jantzen (CFO of APDN), my common stock ownership is 4.36% If I exercised my remaining 110,000 warrants, my ownership would be 6.45%. Read SEC document |
| June 18, 2020 Filed Jun 18, 2020 22:14 UTC |
Montgomery William W5% owner
|
PurchaseApplied DNA Sciences Inc. Common Stock | 40,000 | $5.25 | $210,000.00 |
DisclosureSEC source: 0001763113-20-000003 · primary_doc.xml · nonDerivative · entry 1 Montgomery William W · CIK 0001763113 · 5% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 215,000 F1 · price: cash exercise of warrants (see Table II) Read SEC document |
| June 09, 2020 Filed Jun 10, 2020 00:48 UTC |
Montgomery William W5% Owner
|
PurchaseApplied DNA Sciences Inc. 5 year warrant · Derivative | 75,000 | $2.50 Strike: $5.25 | $187,500.00 |
DisclosureSEC source: 0001763113-20-000002 · primary_doc.xml · derivative · entry 4 Montgomery William W · CIK 0001763113 · 5% Owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 150,000 Underlying: Applied DNA Sciences Inc. Common Stock · 75,000 shares Expires 2024-11-15 F2 · shares: cash exercise of warrants F3 · balance_after: Based on the most recently reported shares outstanding of 4,677,995 (+ 75,000), my common stock ownership is 3.68%. If I exercised all of my warrants my ownership would be 6.63% Read SEC document |
| June 09, 2020 Filed Jun 10, 2020 00:48 UTC |
Montgomery William W5% Owner
|
PurchaseApplied DNA Sciences Inc. Common Stock | 75,000 | $5.25 | $393,750.00 |
DisclosureSEC source: 0001763113-20-000002 · primary_doc.xml · nonDerivative · entry 3 Montgomery William W · CIK 0001763113 · 5% Owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 175,000 F1 · price: cash exercise of warrants (see Table II) Read SEC document |
| June 09, 2020 Filed Jun 10, 2020 00:48 UTC |
Montgomery William W5% Owner
|
PurchaseApplied DNA Sciences Inc. Common Stock | 40,000 | $7.91 | $316,560.00 |
DisclosureSEC source: 0001763113-20-000002 · primary_doc.xml · nonDerivative · entry 2 Montgomery William W · CIK 0001763113 · 5% Owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Read SEC document |
| June 08, 2020 Filed Jun 10, 2020 00:48 UTC |
Montgomery William W5% Owner
|
PurchaseApplied DNA Sciences Inc. Common Stock | 55,000 | $8.06 | $443,498.00 |
DisclosureSEC source: 0001763113-20-000002 · primary_doc.xml · nonDerivative · entry 1 Montgomery William W · CIK 0001763113 · 5% Owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 140,000 Read SEC document |
| June 03, 2020 Filed Jun 4, 2020 20:32 UTC |
Murrah JudithChief Information Officer
|
GrantStock Option (right to buy) · Derivative | 6,965 | $0.00 Strike: $8.36 | $0.00 |
DisclosureSEC source: 0001104659-20-069842 · tm2021815-3_4.xml · derivative · entry 1 Murrah Judith · CIK 0001624562 · Chief Information Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,965 Underlying: Common Stock · 6,965 shares Expires 2030-06-02 F1 · derivative.exercise_date: The options vest immediately Read SEC document |
| June 03, 2020 Filed Jun 4, 2020 20:32 UTC |
Jantzen BethChief Financial Officer
|
GrantStock Option (right to buy) · Derivative | 6,965 | $0.00 Strike: $8.36 | $0.00 |
DisclosureSEC source: 0001104659-20-069841 · tm2021815-2_4.xml · derivative · entry 1 Jantzen Beth · CIK 0001633940 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,965 Underlying: Common Stock · 6,965 shares Expires 2030-06-02 F1 · derivative.exercise_date: The options vest immediately. Read SEC document |
| June 03, 2020 Filed Jun 4, 2020 20:31 UTC |
Hayward James ADirector · Chairman, CEO and President
|
GrantStock Option (right to buy) · Derivative | 6,965 | $0.00 Strike: $8.36 | $0.00 |
DisclosureSEC source: 0001104659-20-069839 · tm2021815-1_4.xml · derivative · entry 1 Hayward James A · CIK 0001357784 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,965 Underlying: Common Stock · 6,965 shares Expires 2030-06-02 F1 · derivative.exercise_date: The options vest immediately. Read SEC document |
| May 22, 2020 Filed May 27, 2020 20:10 UTC |
Simon Sanford RDirector
|
GrantStock Option (right to buy) · Derivative | 13,606 | $0.00 Strike: $11.04 | $0.00 |
DisclosureSEC source: 0001104659-20-066400 · tm2020994-6_4.xml · derivative · entry 1 Simon Sanford R · CIK 0001357785 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,606 Underlying: Common Stock · 13,606 shares Expires 2030-05-21 F1 · derivative.exercise_date: These options vest in full and become exercisable on the first anniversary of the date of grant, subject to continued board membership through such date. Read SEC document |
| May 22, 2020 Filed May 27, 2020 20:10 UTC |
SHAMASH YACOV ADirector
|
GrantStock Option (right to buy) · Derivative | 13,606 | $0.00 Strike: $11.04 | $0.00 |
DisclosureSEC source: 0001104659-20-066398 · tm2020994-5_4.xml · derivative · entry 1 SHAMASH YACOV A · CIK 0001013589 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,606 Underlying: Common Stock · 13,606 shares Expires 2030-05-21 F1 · derivative.exercise_date: These options vest in full and become exercisable on the first anniversary of the date of grant, subject to continued board membership through such date. Read SEC document |
| May 22, 2020 Filed May 27, 2020 20:08 UTC |
Bitzer John IIIDirector
|
GrantStock Option (right to buy) · Derivative | 12,598 | $0.00 Strike: $11.04 | $0.00 |
DisclosureSEC source: 0001104659-20-066394 · tm2020994-1_4.xml · derivative · entry 1 Bitzer John III · CIK 0001624610 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,598 Underlying: Common Stock · 12,598 shares Expires 2030-05-21 F1 · derivative.exercise_date: These options vest in full and become exercisable on the first anniversary of the date of grant, subject to continued board membership through such date. Read SEC document |
| May 22, 2020 Filed May 27, 2020 20:09 UTC |
Schmalz Elizabeth MDirector
|
GrantStock Option (right to buy) · Derivative | 13,606 | $0.00 Strike: $11.04 | $0.00 |
DisclosureSEC source: 0001104659-20-066397 · tm2020994-4_4.xml · derivative · entry 1 Ferguson Elizabeth M. · CIK 0001707145 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,606 Underlying: Common Stock · 13,606 shares Expires 2030-05-21 F1 · derivative.exercise_date: These options vest in full and become exercisable on the first anniversary of the date of grant, subject to continued board membership through such date. Read SEC document |
| May 22, 2020 Filed May 27, 2020 20:09 UTC |
CATELL ROBERT BDirector
|
GrantStock Option (right to buy) · Derivative | 13,606 | $0.00 Strike: $11.04 | $0.00 |
DisclosureSEC source: 0001104659-20-066395 · tm2020994-2_4.xml · derivative · entry 1 CATELL ROBERT B · CIK 0001195325 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,606 Underlying: Common Stock · 13,606 shares Expires 2030-05-21 F1 · derivative.exercise_date: These options vest in full and become exercisable on the first anniversary of the date of grant, subject to continued board membership through such date. Read SEC document |
| May 22, 2020 Filed May 27, 2020 20:09 UTC |
Ceccoli Joseph D.Director
|
GrantStock Option (right to buy) · Derivative | 13,606 | $0.00 Strike: $11.04 | $0.00 |
DisclosureSEC source: 0001104659-20-066396 · tm2020994-3_4.xml · derivative · entry 1 Ceccoli Joseph D. · CIK 0001627545 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,606 Underlying: Common Stock · 13,606 shares Expires 2030-05-21 F1 · derivative.exercise_date: These options vest in full and become exercisable on the first anniversary of the date of grant, subject to continued board membership through such date. Read SEC document |
| March 19, 2020 Filed Mar 21, 2020 00:06 UTC |
Montgomery William W5% Owner
|
PurchaseApplied DNA Sciences Inc. 5 year warrant · Derivative | 0 | $1.25 Strike: $5.25 | $0.00 |
DisclosureSEC source: 0001763113-20-000001 · primary_doc.xml · derivative · entry 2 Montgomery William W · CIK 0001763113 · 5% Owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 225,000 Underlying: Applied DNA Sciences Inc. Common Stock · 0 shares Expires 2024-11-15 F1 · balance_after: Based on the most recently reported shares outstanding of 3,485,399, my common stock ownership is 5.59%. If I exercised all of my warrants that are able to be exercised under the terms of these warrants my ownership would be 9.99% Read SEC document |
| March 19, 2020 Filed Mar 21, 2020 00:06 UTC |
Montgomery William W5% Owner
|
PurchaseApplied DNA Sciences Inc. Common Stock | 30,774 | $8.08 | $248,712.39 |
DisclosureSEC source: 0001763113-20-000001 · primary_doc.xml · nonDerivative · entry 1 Montgomery William W · CIK 0001763113 · 5% Owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 195,000 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.